"Certifiée A sur la V 2014 en décembre 2018, la Polyclinique de Blois développe sa politique qualité autour de 3 axes majeurs : hygiène, qualité de l’accueil et sécurité des soins. Sa mission : être au plus près du patient pour lui apporter un soin de qualité avec une technologie à la pointe. A la pointe du développement, la Polyclinique de Blois investit régulièrement : - acquisition du robot DA Vinci, (outils technologique associant qualité et sécurité des soins et attractivité pour les chirurgiens) . - ouverture d’un plateau technique dédié à l’ophtalmologie - création d’une salle nature : un nouvel espace proposé aux mamans pour vivre autrement son accouchement alliant bien être, sérénité et sécurité."

During the past decade, Polyclinique de Blois conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique de Blois" #1 collaborator was "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique de Blois" are "Breast Neoplasms" (2 trials), "Neoplasm Metastasis" (2 trials), "Abiraterone Acetate" (1 trials), "Androgens" (1 trials) and "Antineoplastic Agents" (1 trials). Many other conditions were trialed in "Polyclinique de Blois" in a lesser frequency.

Most popular intervention types in "Polyclinique de Blois" are "Drug" (5 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (3 trials), "Exemestane" (2 trials), "Imlunestrant" (2 trials), "Abiraterone" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique de Blois" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique de Blois". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Polyclinique de Blois, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique de Blois, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".